Elo Mutual Pension Insurance Co Has $876,000 Position in Henry Schein, Inc. (NASDAQ:HSIC)

Elo Mutual Pension Insurance Co lifted its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 11.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,660 shares of the company’s stock after purchasing an additional 1,285 shares during the period. Elo Mutual Pension Insurance Co’s holdings in Henry Schein were worth $876,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of HSIC. FMR LLC increased its position in Henry Schein by 7.8% during the third quarter. FMR LLC now owns 3,280,890 shares of the company’s stock worth $239,177,000 after buying an additional 237,888 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of Henry Schein by 1.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,191,677 shares of the company’s stock valued at $82,464,000 after buying an additional 16,616 shares during the last quarter. ING Groep NV boosted its stake in shares of Henry Schein by 34.1% during the 4th quarter. ING Groep NV now owns 1,163,087 shares of the company’s stock worth $80,486,000 after acquiring an additional 295,785 shares during the period. Stifel Financial Corp increased its holdings in shares of Henry Schein by 1.2% during the 3rd quarter. Stifel Financial Corp now owns 1,122,455 shares of the company’s stock worth $81,827,000 after acquiring an additional 13,180 shares during the last quarter. Finally, Holocene Advisors LP bought a new stake in Henry Schein in the 3rd quarter valued at $58,319,000. 96.62% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the company’s stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now directly owns 24,805 shares in the company, valued at $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the transaction, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

Henry Schein Stock Performance

NASDAQ:HSIC opened at $68.62 on Monday. The company has a market cap of $8.52 billion, a price-to-earnings ratio of 28.24, a PEG ratio of 2.13 and a beta of 0.90. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.49. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The stock has a fifty day moving average price of $74.62 and a 200-day moving average price of $72.68.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the prior year, the company earned $0.66 EPS. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. As a group, equities analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on HSIC shares. Mizuho assumed coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective on the stock. Wells Fargo & Company began coverage on shares of Henry Schein in a research note on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price target on the stock. Barrington Research reissued an “outperform” rating and issued a $90.00 price target on shares of Henry Schein in a report on Wednesday, February 26th. Jefferies Financial Group boosted their price objective on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Finally, UBS Group lowered their target price on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 26th. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $81.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.